{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T13:02:33Z","timestamp":1789390953280,"version":"build-2803163510"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T00:00:00Z","timestamp":1782518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T00:00:00Z","timestamp":1789344000000},"content-version":"vor","delay-in-days":79,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Discov."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Cisplatin resistance represents a major barrier to effective treatment of lung adenocarcinoma (LUAD), yet its metabolic underpinnings remain incompletely defined. Here, we demonstrate that the transcription factor KLF15 governs cisplatin sensitivity by orchestrating mitochondrial biogenesis and redox homeostasis. KLF15 is downregulated in cisplatin-resistant LUAD cells, which display reduced mitochondrial content and suppressed reactive oxygen species (ROS) accumulation. Restoring KLF15 expression resensitizes LUAD cells to cisplatin both in vitro and in vivo. Mechanistically, KLF15 directly transactivates PGC1\u03b1, and loss of PGC1\u03b1 abrogates KLF15-mediated cisplatin sensitization, restoring drug resistance by attenuating apoptosis. Functionally, LUAD subpopulations with low mitochondrial mass or low KLF15 expression exhibit intrinsic resistance, whereas Mito-high xenografts show enhanced therapeutic response. Together, our findings identify a KLF15-PGC1\u03b1 regulatory axis that dictates mitochondrial reprogramming and cisplatin responsiveness, highlighting a potential therapeutic axis to overcome chemoresistance in LUAD.<\/jats:p>","DOI":"10.1038\/s41420-026-03235-3","type":"journal-article","created":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T05:14:44Z","timestamp":1782537284000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["KLF15 activates PGC1\u03b1 to rewire mitochondrial homeostasis and overcome cisplatin resistance in lung adenocarcinoma"],"prefix":"10.1038","volume":"12","author":[{"given":"Wan","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuwen","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruikun","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianqun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8728-893X","authenticated-orcid":false,"given":"Xiaodong","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,27]]},"reference":[{"key":"3235_CR1","first-page":"10","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A. Cancer statistics, 2025. CA Cancer J Clin. 2025;75:10\u201345.","journal-title":"CA Cancer J Clin"},{"key":"3235_CR2","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1136\/jim-2021-002159","volume":"70","author":"J Yu","year":"2022","unstructured":"Yu J, Zhang Q, Li J, Si Z, Guo Y, Xu X, et al. Sequential administration of pemetrexed and cisplatin reprograms tumor immune microenvironment and potentiates PD-1\/PD-L1 treatment in a lung cancer model. J Investig Med. 2022;70:792\u20139.","journal-title":"J Investig Med"},{"key":"3235_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1002938","volume":"13","author":"X Dong","year":"2022","unstructured":"Dong X, Huang Y, Yi T, Hu C, Gao Q, Chen Y, et al. Intrapleural infusion of tumor cell-derived microparticles packaging methotrexate or saline combined with pemetrexed-cisplatin chemotherapy for the treatment of malignant pleural effusion in advanced non-squamous non-small cell lung cancer: A double-blind, randomized, placebo-controlled study. Front Immunol. 2022;13:1002938.","journal-title":"Front Immunol"},{"key":"3235_CR4","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.canlet.2020.10.032","volume":"497","author":"Y Li","year":"2021","unstructured":"Li Y, Chen Y, Miao L, Wang Y, Yu M, Yan X, et al. Stress-induced upregulation of TNFSF4 in cancer-associated fibroblast facilitates chemoresistance of lung adenocarcinoma through inhibiting apoptosis of tumor cells. Cancer Lett. 2021;497:212\u201320.","journal-title":"Cancer Lett"},{"key":"3235_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-021-01355-1","volume":"20","author":"Y Cheng","year":"2021","unstructured":"Cheng Y, Mo F, Li Q, Han X, Shi H, Chen S, et al. Targeting CXCR2 inhibits the progression of lung cancer and promotes therapeutic effect of cisplatin. Mol Cancer. 2021;20:62.","journal-title":"Mol Cancer"},{"key":"3235_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-022-03372-0","volume":"20","author":"Q Sui","year":"2022","unstructured":"Sui Q, Chen Z, Hu Z, Huang Y, Liang J, Bi G, et al. Cisplatin resistance-related multi-omics differences and the establishment of machine learning models. J Transl Med. 2022;20:171.","journal-title":"J Transl Med"},{"key":"3235_CR7","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.7150\/thno.69424","volume":"12","author":"C Zhang","year":"2022","unstructured":"Zhang C, Xu C, Gao X, Yao Q. Platinum-based drugs for cancer therapy and anti-tumor strategies. Theranostics. 2022;12:2115\u201332.","journal-title":"Theranostics"},{"key":"3235_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2022.e10608","volume":"8","author":"R Ranasinghe","year":"2022","unstructured":"Ranasinghe R, Mathai ML, Zulli A. Cisplatin for cancer therapy and overcoming chemoresistance. Heliyon. 2022;8:e10608.","journal-title":"Heliyon"},{"key":"3235_CR9","doi-asserted-by":"publisher","first-page":"7241","DOI":"10.3390\/ijms23137241","volume":"23","author":"R Ali","year":"2022","unstructured":"Ali R, Aouida M, Alhaj Sulaiman A, Madhusudan S, Ramotar D. Can Cisplatin Therapy Be Improved? Pathways That Can Be Targeted. Int J Mol Sci. 2022;23:7241.","journal-title":"Int J Mol Sci"},{"key":"3235_CR10","doi-asserted-by":"publisher","first-page":"303","DOI":"10.2147\/JEP.S267383","volume":"13","author":"PB Tchounwou","year":"2021","unstructured":"Tchounwou PB, Dasari S, Noubissi FK, Ray P, Kumar S. Advances in Our Understanding of the Molecular Mechanisms of Action of Cisplatin in Cancer Therapy. J Exp Pharm. 2021;13:303\u201328.","journal-title":"J Exp Pharm"},{"key":"3235_CR11","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.3390\/biom12101365","volume":"12","author":"Y Lugones","year":"2022","unstructured":"Lugones Y, Loren P, Salazar LA. Cisplatin Resistance: Genetic and Epigenetic Factors Involved. Biomolecules. 2022;12:1365.","journal-title":"Biomolecules"},{"key":"3235_CR12","doi-asserted-by":"publisher","first-page":"287","DOI":"10.3390\/cells8040287","volume":"8","author":"C Bouchez","year":"2019","unstructured":"Bouchez C, Devin A. Mitochondrial Biogenesis and Mitochondrial Reactive Oxygen Species (ROS): A Complex Relationship Regulated by the cAMP\/PKA Signaling Pathway. Cells. 2019;8:287.","journal-title":"Cells"},{"key":"3235_CR13","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.freeradbiomed.2012.04.033","volume":"53","author":"T Yamamori","year":"2012","unstructured":"Yamamori T, Yasui H, Yamazumi M, Wada Y, Nakamura Y, Nakamura H, et al. Ionizing radiation induces mitochondrial reactive oxygen species production accompanied by upregulation of mitochondrial electron transport chain function and mitochondrial content under control of the cell cycle checkpoint. Free Radic Biol Med. 2012;53:260\u201370.","journal-title":"Free Radic Biol Med"},{"key":"3235_CR14","doi-asserted-by":"publisher","first-page":"3175","DOI":"10.1002\/pmic.201300015","volume":"13","author":"P Mu","year":"2013","unstructured":"Mu P, Xu M, Zhang L, Wu K, Wu J, Jiang J, et al. Proteomic changes in chicken primary hepatocytes exposed to T-2 toxin are associated with oxidative stress and mitochondrial enhancement. Proteomics. 2013;13:3175\u201388.","journal-title":"Proteomics"},{"key":"3235_CR15","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/s41420-024-01953-0","volume":"10","author":"W You","year":"2024","unstructured":"You W, Knoops K, Berendschot T, Benedikter BJ, Webers CAB, Reutelingsperger CPM, et al. PGC-1a mediated mitochondrial biogenesis promotes recovery and survival of neuronal cells from cellular degeneration. Cell Death Discov. 2024;10:180.","journal-title":"Cell Death Discov"},{"key":"3235_CR16","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.mito.2013.01.006","volume":"13","author":"T Wenz","year":"2013","unstructured":"Wenz T. Regulation of mitochondrial biogenesis and PGC-1alpha under cellular stress. Mitochondrion. 2013;13:134\u201342.","journal-title":"Mitochondrion"},{"key":"3235_CR17","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1038\/nature19347","volume":"537","author":"C Luo","year":"2016","unstructured":"Luo C, Lim JH, Lee Y, Granter SR, Thomas A, Vazquez F, et al. A PGC1alpha-mediated transcriptional axis suppresses melanoma metastasis. Nature. 2016;537:422\u20136.","journal-title":"Nature"},{"key":"3235_CR18","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/ncb3357","volume":"18","author":"V Torrano","year":"2016","unstructured":"Torrano V, Valcarcel-Jimenez L, Cortazar AR, Liu X, Urosevic J, Castillo-Martin M, et al. The metabolic co-regulator PGC1alpha suppresses prostate cancer metastasis. Nat Cell Biol. 2016;18:645\u201356.","journal-title":"Nat Cell Biol"},{"key":"3235_CR19","doi-asserted-by":"publisher","first-page":"6153","DOI":"10.1158\/0008-5472.CAN-19-1231","volume":"79","author":"L Valcarcel-Jimenez","year":"2019","unstructured":"Valcarcel-Jimenez L, Macchia A, Crosas-Molist E, Schaub-Clerigue A, Camacho L, Martin-Martin N, et al. PGC1alpha Suppresses Prostate Cancer Cell Invasion through ERRalpha Transcriptional Control. Cancer Res. 2019;79:6153\u201365.","journal-title":"Cancer Res"},{"key":"3235_CR20","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1152\/physrev.00058.2009","volume":"90","author":"BB McConnell","year":"2010","unstructured":"McConnell BB, Yang VW. Mammalian Kruppel-like factors in health and diseases. Physiol Rev. 2010;90:1337\u201381.","journal-title":"Physiol Rev"},{"key":"3235_CR21","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.ebiom.2019.01.021","volume":"40","author":"MJ Rane","year":"2019","unstructured":"Rane MJ, Zhao Y, Cai L. Kruppel-like factors (KLFs) in renal physiology and disease. EBioMedicine. 2019;40:743\u201350.","journal-title":"EBioMedicine"},{"key":"3235_CR22","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s13402-015-0226-8","volume":"38","author":"T Yoda","year":"2015","unstructured":"Yoda T, McNamara KM, Miki Y, Onodera Y, Takagi K, Nakamura Y, et al. KLF15 in breast cancer: a novel tumor suppressor? Cell Oncol (Dordr). 2015;38:227\u201335.","journal-title":"Cell Oncol (Dordr)"},{"key":"3235_CR23","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.biopha.2018.07.006","volume":"106","author":"X Wang","year":"2018","unstructured":"Wang X, He M, Li J, Wang H, Huang J. KLF15 suppresses cell growth and predicts prognosis in lung adenocarcinoma. Biomed Pharmacother. 2018;106:672\u20137.","journal-title":"Biomed Pharmacother"},{"key":"3235_CR24","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1007\/s10620-017-4558-2","volume":"62","author":"C Sun","year":"2017","unstructured":"Sun C, Ma P, Wang Y, Liu W, Chen Q, Pan Y, et al. KLF15 Inhibits Cell Proliferation in Gastric Cancer Cells via Up-Regulating CDKN1A\/p21 and CDKN1C\/p57 Expression. Dig Dis Sci. 2017;62:1518\u201326.","journal-title":"Dig Dis Sci"},{"key":"3235_CR25","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s12860-020-00310-0","volume":"21","author":"Y Liu","year":"2020","unstructured":"Liu Y, Cheng T, Du Y, Hu X, Xia W. LncRNA LUCAT1\/miR-181a-5p axis promotes proliferation and invasion of breast cancer via targeting KLF6 and KLF15. BMC Mol Cell Biol. 2020;21:69.","journal-title":"BMC Mol Cell Biol"},{"key":"3235_CR26","doi-asserted-by":"publisher","first-page":"620","DOI":"10.3390\/metabo11090620","volume":"11","author":"L Li","year":"2021","unstructured":"Li L, Xu W, Zhang L. KLF15 Regulates Oxidative Stress Response in Cardiomyocytes through NAD. Metabolites. 2021;11:620.","journal-title":"Metabolites"},{"key":"3235_CR27","doi-asserted-by":"publisher","DOI":"10.1172\/JCI139496","volume":"131","author":"L Fan","year":"2021","unstructured":"Fan L, Sweet DR, Prosdocimo DA, Vinayachandran V, Chan ER, Zhang R, et al. Muscle Kruppel-like factor 15 regulates lipid flux and systemic metabolic homeostasis. J Clin Invest. 2021;131:e139496.","journal-title":"J Clin Invest"},{"key":"3235_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-022-02449-6","volume":"22","author":"KY Zhu","year":"2022","unstructured":"Zhu KY, Tian Y, Li YX, Meng QX, Ge J, Cao XC, et al. The functions and prognostic value of Kruppel-like factors in breast cancer. Cancer Cell Int. 2022;22:23.","journal-title":"Cancer Cell Int"},{"key":"3235_CR29","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.redox.2014.12.003","volume":"4","author":"L Poillet-Perez","year":"2015","unstructured":"Poillet-Perez L, Despouy G, Delage-Mourroux R, Boyer-Guittaut M. Interplay between ROS and autophagy in cancer cells, from tumor initiation to cancer therapy. Redox Biol. 2015;4:184\u201392.","journal-title":"Redox Biol"},{"key":"3235_CR30","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1186\/s13046-016-0457-1","volume":"35","author":"N Yao","year":"2016","unstructured":"Yao N, Li YJ, Lei YH, Hu N, Chen WM, Yao Z, et al. A piperazidine derivative of 23-hydroxy betulinic acid induces a mitochondria-derived ROS burst to trigger apoptotic cell death in hepatocellular carcinoma cells. J Exp Clin Cancer Res. 2016;35:192.","journal-title":"J Exp Clin Cancer Res"},{"key":"3235_CR31","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.3390\/molecules26082382","volume":"26","author":"S Mirzaei","year":"2021","unstructured":"Mirzaei S, Hushmandi K, Zabolian A, Saleki H, Torabi SMR, Ranjbar A, et al. Elucidating Role of Reactive Oxygen Species (ROS) in Cisplatin Chemotherapy: A Focus on Molecular Pathways and Possible Therapeutic Strategies. Molecules. 2021;26:2382.","journal-title":"Molecules"},{"key":"3235_CR32","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-022-01900-y","volume":"40","author":"KN ArulJothi","year":"2022","unstructured":"ArulJothi KN, Kumaran K, Senthil S, Nidhu AB, Munaff N, Janitri VB, et al. Implications of reactive oxygen species in lung cancer and exploiting it for therapeutic interventions. Med Oncol. 2022;40:43.","journal-title":"Med Oncol"},{"key":"3235_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fspor.2021.714148","volume":"3","author":"M Ihsan","year":"2021","unstructured":"Ihsan M, Abbiss CR, Allan R. Adaptations to Post-exercise Cold Water Immersion: Friend, Foe, or Futile? Front Sports Act Living. 2021;3:714148.","journal-title":"Front Sports Act Living"},{"key":"3235_CR34","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.2337\/db12-0703","volume":"62","author":"LN Zhang","year":"2013","unstructured":"Zhang LN, Zhou HY, Fu YY, Li YY, Wu F, Gu M, et al. Novel small-molecule PGC-1alpha transcriptional regulator with beneficial effects on diabetic db\/db mice. Diabetes. 2013;62:1297\u2013307.","journal-title":"Diabetes"},{"key":"3235_CR35","doi-asserted-by":"crossref","unstructured":"Liu R, Zhang H, Zhang Y, Li S, Wang X, Wang X, et al. Peroxisome proliferator-activated receptor gamma coactivator-1 alpha acts as a tumor suppressor in hepatocellular carcinoma. Tumour Biol 2017;39:1010428317695031.","DOI":"10.1177\/1010428317695031"},{"key":"3235_CR36","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1158\/1940-6207.CAPR-17-0329","volume":"11","author":"F de Souza-Teixeira","year":"2018","unstructured":"de Souza-Teixeira F, Alonso-Molero J, Ayan C, Vilorio-Marques L, Molina AJ, Gonzalez-Donquiles C, et al. PGC-1alpha as a Biomarker of Physical Activity-Protective Effect on Colorectal Cancer. Cancer Prev Res. 2018;11:523\u201334.","journal-title":"Cancer Prev Res"},{"key":"3235_CR37","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.celrep.2015.06.006","volume":"12","author":"EL LaGory","year":"2015","unstructured":"LaGory EL, Wu C, Taniguchi CM, Ding CC, Chi JT, von Eyben R, et al. Suppression of PGC-1alpha Is Critical for Reprogramming Oxidative Metabolism in Renal Cell Carcinoma. Cell Rep. 2015;12:116\u201327.","journal-title":"Cell Rep"},{"key":"3235_CR38","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/cr.2007.11","volume":"17","author":"Y Zhang","year":"2007","unstructured":"Zhang Y, Ba Y, Liu C, Sun G, Ding L, Gao S, et al. PGC-1alpha induces apoptosis in human epithelial ovarian cancer cells through a PPARgamma-dependent pathway. Cell Res. 2007;17:363\u201373.","journal-title":"Cell Res"},{"key":"3235_CR39","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1038\/ncb3039","volume":"16","author":"VS LeBleu","year":"2014","unstructured":"LeBleu VS, O\u2019Connell JT, Gonzalez Herrera KN, Wikman H, Pantel K, Haigis MC, et al. PGC-1alpha mediates mitochondrial biogenesis and oxidative phosphorylation in cancer cells to promote metastasis. Nat Cell Biol. 2014;16:992\u20131003.","journal-title":"Nat Cell Biol"}],"container-title":["Cell Death Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41420-026-03235-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-026-03235-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-026-03235-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T12:04:10Z","timestamp":1789387450000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41420-026-03235-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,27]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3235"],"URL":"https:\/\/doi.org\/10.1038\/s41420-026-03235-3","relation":{},"ISSN":["2058-7716"],"issn-type":[{"value":"2058-7716","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,27]]},"assertion":[{"value":"8 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"All experimental procedures involving human tissues and animals were performed in accordance with relevant institutional guidelines, national regulations, the Guide for the Care and Use of Laboratory Animals and the principles of the Declaration of Helsinki. The overall study protocol was reviewed and approved by the Ethics Committee of Harbin Medical University Cancer Hospital (Approval No.: KY2024-85). A waiver of informed consent was officially granted by the ethics committee for the collection and use of clinical specimens in this study.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"369"}}